LicianPro

DSGN holders · CITADEL ADVISORS LLC 13F · DSGN stock

CITADEL ADVISORS LLC Design Therapeutics Inc (DSGN) 13F holding

CITADEL ADVISORS LLC reported 231,513 DSGN shares valued at $2.5M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest DSGN 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the DSGN holders table.

DSGN reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-31231,513$2.5MCOM
2025-12-31459,874$4.3MCOM
2025-09-30554,020$4.2MCOM
2025-06-30840,793$2.8MCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.